Metrological Challenges and Prospects in the Field of Life Sciences

LIU Yahui; ZHAO Yang; XUE Zhichao; NIU Chunyan; LIU Yingying; DONG Lianhua

doi:10.12338/j.issn.2096-9015.2023.0008

Volume 67 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Article Navigation > Metrology Science and Technology > 2023 > 67(2): 13-17

LIU Yahui, ZHAO Yang, XUE Zhichao, NIU Chunyan, LIU Yingying, DONG Lianhua. Metrological Challenges and Prospects in the Field of Life Sciences[J]. Metrology Science and Technology, 2023, 67(2): 13-17. doi: 10.12338/j.issn.2096-9015.2023.0008

Citation:

LIU Yahui, ZHAO Yang, XUE Zhichao, NIU Chunyan, LIU Yingying, DONG Lianhua. Metrological Challenges and Prospects in the Field of Life Sciences[J]. Metrology Science and Technology, 2023, 67(2): 13-17. doi: 10.12338/j.issn.2096-9015.2023.0008

Citation:

PDF( 513 KB)

Metrological Challenges and Prospects in the Field of Life Sciences

doi: 10.12338/j.issn.2096-9015.2023.0008

National Institute of Metrology, Beijing 100029, China

Received Date: 2023-01-06
Accepted Date: 2023-01-31
Rev Recd Date: 2023-03-06

Available Online: 2023-03-10

Publish Date: 2023-02-18

Abstract

Abstract

The global outbreak of COVID-19 has brought healthcare and the life science industry into the spotlight, raising people's attention to disease prevention, treatment, research and development of biological drugs, in vitro diagnosis, and internet medicine. Metrology technology plays a critical role in supporting these fields. The study of metrology technology in life sciences is an essential component of serving public health and a solid foundation for promoting the development of the health and life sciences industry. This paper explores the development ideas of metrology science to support life sciences through literature research, case studies, and the analysis of the strategic reports of domestic and international metrology institutions. Based on this analysis, we propose some suggestions for developing biological metrology in China.
- metrology,
- life science,
- strategic planning,
- biological drugs,
- biometric

FullText(HTML)

References(28)

References

[1]	WANG A P, LI Y Y, YOU X J, et al. Electrochemical immunosensor nanoarchitectonics with the Ag-rGO nanocomposites for the detection of receptor-binding domain of SARS-CoV-2 spike protein[J]. Journal of Solid State Electrochemistry, 2023, 27: 489-499. doi: 10.1007/s10008-022-05330-8
[2]	BAKER M. Reproducibility crisis: Blame it on the antibodies[J]. Nature, 2015, 521: 274-276. doi: 10.1038/521274a
[3]	BAKER M. Irreproducible biology research costs put at $28 billion per year[J]. Nature, 2015, 6: 1-2.
[4]	MCNUTT M. Reproducibility[J]. Science, 2014, 343(6168): 229. doi: 10.1126/science.1250475
[5]	COLLINS F S, TABAK L A. Policy: NIH plans to enhance reproducibility[J]. Nature, 2014, 505(7485): 612-613. doi: 10.1038/505612a
[6]	GREEN E D, WATSON J D, COLLINS F S. Human Genome Project: Twenty-five years of big biology[J]. Nature, 2015, 526(7571): 29-31. doi: 10.1038/526029a
[7]	NOSEK B A, ERRINGTON T M. Making sense of replications[J]. eLife, 2017, 6(e23383): 1-2.
[8]	刘佳畅, 贾亚青, 崔磊, 等. 虹膜采集仪光生物安全性能测试方法研究[J]. 计量科学与技术, 2021, 65(9): 66-69.
[9]	THOMAS D. New Clinical Development Success Rates 2011-2020 Report[EB/OL]. [2022-12-29].https://www.bio.org/clinical-development-success-rates-and-contributing-factors-2011-2020.
[10]	WONG C H, SIAH K W, LO A W. Estimation of clinical trial success rates and related parameters[J]. Biostatistics, 2019, 20(2): 273-286. doi: 10.1093/biostatistics/kxx069
[11]	GRIBKOFF V K, KACZMAREK L K. The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes[J]. Neuropharmacology, 2017, 120: 11-19. doi: 10.1016/j.neuropharm.2016.03.021
[12]	赵雨佳, 廖湉毅, 范培蕾, 等. 新型冠状病毒核酸检测方法及标准物质的研究进展[J]. 计量科学与技术, 2022, 66(1): 3-8.
[13]	国家卫生计生委. 医疗机构临床检验项目目录[EB/OL]. (2013-08-07) [2022-12-29]. http://www.nhc.gov.cn/yzygj/s3593/201308/3f8e4ad3639b419595c310325b571fa3.shtml.
[14]	JCTLM. The JCTLM Database[EB/OL]. [2022-12-29].https://www.jctlmdb.org/#/app/home.
[15]	刘健仪, 宋德伟, 张金萍, 等. 中国体外诊断试剂溯源研究进展[J]. 计量技术, 2020(7): 8-12.
[16]	李达, 王军, 杨忠等. 核酸标准物质定值的实验体系研究[J]. 计量学报, 2020, 41(11): 1436-1442.
[17]	欧元祝, 陈宝荣, 居漪. 临床化学检测的标准化现状[J]. 检验医学, 2021, 36(3): 240-244. doi: 10.3969/j.issn.1673-8640.2021.03.002
[18]	张永卓, 高颖, 牛春艳等. 生物表型和表型组标准化的现状与展望[J]. 计量学报, 2022, 43(10): 1382-1388.
[19]	李晓, 张欣涛, 郝擎, 等. 2020年国家医疗器械抽检体外诊断试剂品种质量状况分析[J]. 中国医疗器械杂志, 2022, 46(4): 459-463. doi: 10.3969/j.issn.1671-7104.2022.04.022
[20]	李成伟, 李姣, 张璞, 等. 重复经颅磁刺激治疗仪的发展与检测需求分析[J]. 计量科学与技术, 2022, 66(6): 45-48,9.
[21]	INFUSINO I, FRUSCIANTE E, BRAGA F, et al, Progress and impact of enzyme measurement standardization[J]. Clinical chemistry and laboratory medicine, 2017, 55(3): 334-340.
[22]	SHI L, KUSKO R, WOLFINGER R D, et al, The international MAQC Society launches to enhance reproducibility of high-throughput technologies[J]. Nature biotechnology, 2017, 35(12): 1127-1128.
[23]	隋志伟, 王梓权, 刘思渊, 等. 微生物计量技术研究进展及发展趋势[J]. 计量科学与技术, 2021, 65(6): 54-59, 53.
[24]	MILAVEC M, CLEVELAND M H, BAE Y K, et al. Metrological framework to support accurate, reliable, and reproducible nucleic acid measurements[J]. Analytical and bioanalytical chemistry, 2021, 414(2): 791-806.
[25]	DURAZZO A, SORKIN B C, LUCARINI M, et al. Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives[J]. Frontiers in pharmacology, 2022, 12: 1-23.
[26]	DAGHER G, BECKER K F, BONIN S, et al. Pre-analytical processes in medical diagnostics: New regulatory requirements and standards[J]. New biotechnology, 2019, 52: 121-125.
[27]	DEUTSCH E W, ALBAR J P, BINZ P A, et al. Development of data representation standards by the human proteome organization proteomics standards initiative[J]. Journal of the American medical informatics association, 2015, 22(3): 495-506.
[28]	GANGULY D. Multi-omics studies in interpreting the evolving standard model for immune functions[J].Briefings in functional genmomics, 2023. doi: 10.1093/bfgp/elad003.